| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Greenwich Lifesciences, Inc. (GLSI) has 1 insider with recent SEC Form 4 filings, including 10 buys and 0 sells. GLSI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.61M | $80.75M | +7.3K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2022 | Patel Snehal61 | CEO And CFO | Buy | 8,000 | $7.13 | $57,040.00 | +0.3% | +35.7% | +52.7% | |
| Jun 14, 2022 | Patel Snehal61 | CEO And CFO | Buy | 12,000 | $7.91 | $94,920.00 | +0.5% | +31.1% | +41.9% | |
| Jun 10, 2022 | Patel Snehal61 | CEO And CFO | Buy | 12,000 | $8.33 | $99,960.00 | +0.5% | +12.3% | +30.6% | |
| Jun 9, 2022 | Patel Snehal61 | CEO And CFO | Buy | 4,500 | $10.90 | $49,050.00 | +0.4% | -16.6% | +3.6% | |
| Jun 7, 2022 | Patel Snehal61 | CEO And CFO | Buy | 6,000 | $8.55 | $51,300.00 | +0.5% | +0.8% | +34.2% | |
| Jun 3, 2022 | Patel Snehal61 | CEO And CFO | Buy | 9,250 | $8.35 | $77,237.50 | +0.8% | -2.7% | +21.8% | |
| Jun 2, 2022 | Patel Snehal61 | CEO And CFO | Buy | 6,774 | $7.38 | $49,992.12 | +0.6% | +20.3% | +39.2% | |
| Apr 25, 2022 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1,000 | $16.25 | $16,250.00 | +1.1% | -47.0% | -30.8% | |
| Apr 21, 2022 | Patel Snehal61 | CEO And CFO | Buy | 6,000 | $16.09 | $96,540.00 | +0.5% | -43.8% | -27.6% | |
| Apr 19, 2022 | Patel Snehal61 | CEO And CFO | Buy | 6,000 | $16.74 | $100,440.00 | +0.5% | -47.7% | -33.0% |